These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30335007)

  • 21. Effect of growth hormone therapy on liver enzyme and other cardiometabolic risk factors in boys with obesity and nonalcoholic fatty liver disease.
    Xue J; Liang S; Ma J; Xiao Y
    BMC Endocr Disord; 2022 Feb; 22(1):49. PubMed ID: 35216556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudotumor cerebri and prolactin secreting pituitary adenoma. Association or coincidence?
    Jamjoom BA; Sharab MA; Nasser TA; Jamjoom AB
    Neurosciences (Riyadh); 2010 Jul; 15(3):200-3. PubMed ID: 20831031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin-producing pituitary adenoma with atypical spindle cell morphology: a case report.
    Inoue R; Aoki M; Matsumoto Y; Haraoka S; Kazekawa K; Nabeshima K
    World J Surg Oncol; 2015 Jul; 13():229. PubMed ID: 26228535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated double pituitary adenomas: A silent corticotroph adenoma and a microprolactinoma.
    Eytan S; Kim KY; Bleich D; Raghuwanshi M; Eloy JA; Liu JK
    J Clin Neurosci; 2015 Oct; 22(10):1676-8. PubMed ID: 26067545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prolactin-secreting microadenoma in menopausal women].
    Barka I; Dendana E; Chikhrouhou N; Maroufi A; Kacem M; Chadli M; Ach K
    Pan Afr Med J; 2017; 27():177. PubMed ID: 28904704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sellar Wegener Granulomatosis Masquerading as Cabergoline-Resistant Prolactinoma.
    Eli IM; Raheja A; Corn HJ; Simmons DL; Palmer CA; Couldwell WT
    World Neurosurg; 2016 Nov; 95():622.e1-622.e5. PubMed ID: 27521731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma.
    Hwang YA; Lee HW; Ahn SH; Lee EJ; Ku CR; Kim SU
    Front Endocrinol (Lausanne); 2022; 13():1057769. PubMed ID: 36699040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discrimination of prolactinoma from hyperprolactinemic non-functioning adenoma.
    Hong JW; Lee MK; Kim SH; Lee EJ
    Endocrine; 2010 Feb; 37(1):140-7. PubMed ID: 20963563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cabergoline: a first-choice treatment in patients with previously untreated prolactin-secreting pituitary adenoma.
    Cannavò S; Curtò L; Squadrito S; Almoto B; Vieni A; Trimarchi F
    J Endocrinol Invest; 1999 May; 22(5):354-9. PubMed ID: 10401709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.
    Selvakumar PKC; Kabbany MN; Nobili V; Alkhouri N
    Pediatr Clin North Am; 2017 Jun; 64(3):659-675. PubMed ID: 28502444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.
    de Piano A; de Mello MT; Sanches Pde L; da Silva PL; Campos RM; Carnier J; Corgosinho F; Foschini D; Masquio DL; Tock L; Oyama LM; do Nascimento CM; Tufik S; Dâmaso AR
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1313-24. PubMed ID: 22932160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shrinkage of a PRL-secreting pituitary macroadenoma resistant to cabergoline.
    Cannavò S; Bartolone L; Blandino A; Spinella S; Galatioto S; Trimarchi F
    J Endocrinol Invest; 1999 Apr; 22(4):306-9. PubMed ID: 10342366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response.
    Strowd RE; Salvatori R; Laterra JJ
    J Oncol Pharm Pract; 2016 Jun; 22(3):517-22. PubMed ID: 25616657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A middle cerebral artery ischemic stroke occurring in a child with a large prolactinoma.
    Oh T; Amara D; Gupta N; Clerkin P
    Childs Nerv Syst; 2020 Apr; 36(4):853-856. PubMed ID: 31853893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menstrual abnormalities in a woman with ACTH-dependent pituitary macroadenoma mimicking polycystic ovary syndrome.
    Liao CC; Lin SY; Lin HW; Chen KH; Chang LH; Chen ST; Wang J
    Taiwan J Obstet Gynecol; 2006 Jun; 45(2):176-9. PubMed ID: 17197364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolactinoma - which patients react favorably to cabergoline medication?
    Karatas S; Hacioglu Y; Rakicioglu T
    Endocr Regul; 2022 Oct; 56(4):279-283. PubMed ID: 36270341
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperprolactinemia: pathophysiology and management.
    Verhelst J; Abs R
    Treat Endocrinol; 2003; 2(1):23-32. PubMed ID: 15871552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactinoma and estrogens: pregnancy, contraception and hormonal replacement therapy.
    Christin-Maître S; Delemer B; Touraine P; Young J
    Ann Endocrinol (Paris); 2007 Jun; 68(2-3):106-12. PubMed ID: 17540335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
    Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR
    J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.